Randomized Phase 3 Trial of the Hypoxia Modifier Nimorazole Added to Radiation Therapy With Benefit Assessed in Hypoxic Head and Neck Cancers Determined Using a Gene Signature (NIMRAD).

Thomson, David J; Slevin, Nick J; Baines, Helen; Betts, Guy; Bolton, Steve; Evans, Mererid; Garcez, Kate; Irlam, Joely; Lee, Lip; Melillo, Nicola; Mistry, Hitesh; More, Elisabet; Nutting, Christopher; Price, James M; Schipani, Stefano; Sen, Mehmet; Yang, Huiqi; West, Catharine M

Thomson, David J; Slevin, Nick J; Baines, Helen; Betts, Guy; Bolton, Steve; Evans, Mererid; Garcez, Kate; Irlam, Joely; Lee, Lip; Melillo, Nicola; Mistry, Hitesh; More, Elisabet; Nutting, Christopher; Price, James M; Schipani, Stefano; Sen, Mehmet; Yang, Huiqi; West, Catharine M.

Afiliación

Thomson DJ; The Christie NHS Foundation Trust, Manchester, United Kingdom; University of Liverpool, Liverpool, United Kingdom; Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, United Kingdom.
Slevin NJ; The Christie NHS Foundation Trust, Manchester, United Kingdom.
Baines H; National Radiotherapy Trials Quality Assurance (RTTQA) Group, Northwood, United Kingdom; Royal Marsden NHS Foundation Trust, London, United Kingdom.
Betts G; Manchester University NHS Foundation Trust, Manchester, United Kingdom.
Bolton S; The Christie NHS Foundation Trust, Manchester, United Kingdom.
Evans M; Cardiff University and Velindre Cancer Centre, Cardiff, United Kingdom.
Garcez K; The Christie NHS Foundation Trust, Manchester, United Kingdom.
Irlam J; Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, United Kingdom.
Lee L; The Christie NHS Foundation Trust, Manchester, United Kingdom.
Melillo N; SystemsForecastingUK Ltd, Lancaster, United Kingdom.
Mistry H; Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, United Kingdom; SystemsForecastingUK Ltd, Lancaster, United Kingdom.
More E; Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, United Kingdom.
Nutting C; Royal Marsden NHS Foundation Trust, London, United Kingdom.
Price JM; The Christie NHS Foundation Trust, Manchester, United Kingdom.
Schipani S; Beatson West of Scotland Cancer Centre and University of Glasgow, Glasgow, United Kingdom.
Sen M; Leeds Teaching Hospital NHS Trust, Leeds, United Kingdom.
Yang H; National Radiotherapy Trials Quality Assurance (RTTQA) Group, Northwood, United Kingdom; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
West CM; Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, United Kingdom. Electronic address: catharine.west@manchester.ac.uk.

Int J Radiat Oncol Biol Phys ; 2023 Dec 09.

Article en En | MEDLINE | ID: mdl-38072326

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Int J Radiat Oncol Biol Phys Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido